- Home
- INTS vs SHOT Comparison
INTS vs SHOT Comparison
Compare INTS & SHOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- SHOT
- Stock Information
- Founded
- INTS 2012
- SHOT 2018
- Country
- INTS United States
- SHOT United States
- Employees
- INTS N/A
- SHOT N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- SHOT Biotechnology: Pharmaceutical Preparations
- Sector
- INTS Health Care
- SHOT Health Care
- Exchange
- INTS Nasdaq
- SHOT Nasdaq
- Market Cap
- INTS 7.4M
- SHOT 30.4M
- IPO Year
- INTS 2023
- SHOT 2020
- Fundamental
- Price
- INTS $0.33
- SHOT $0.43
- Analyst Decision
- INTS Strong Buy
- SHOT
- Analyst Count
- INTS 3
- SHOT 0
- Target Price
- INTS $8.50
- SHOT N/A
- AVG Volume (30 Days)
- INTS 3.7M
- SHOT 6.3M
- Earning Date
- INTS 08-07-2025
- SHOT 08-13-2025
- Dividend Yield
- INTS N/A
- SHOT N/A
- EPS Growth
- INTS N/A
- SHOT N/A
- EPS
- INTS N/A
- SHOT N/A
- Revenue
- INTS N/A
- SHOT $573,336.00
- Revenue This Year
- INTS N/A
- SHOT N/A
- Revenue Next Year
- INTS N/A
- SHOT N/A
- P/E Ratio
- INTS N/A
- SHOT N/A
- Revenue Growth
- INTS N/A
- SHOT 69.32
- 52 Week Low
- INTS $0.26
- SHOT $0.23
- 52 Week High
- INTS $5.10
- SHOT $1.77
- Technical
- Relative Strength Index (RSI)
- INTS 41.29
- SHOT 54.76
- Support Level
- INTS $0.26
- SHOT $0.35
- Resistance Level
- INTS $0.32
- SHOT $0.48
- Average True Range (ATR)
- INTS 0.03
- SHOT 0.06
- MACD
- INTS 0.02
- SHOT 0.01
- Stochastic Oscillator
- INTS 62.56
- SHOT 46.94
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About SHOT Safety Shot Inc.
Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.